Kaplan-Meier cumulative incidences of different clinical end-points in three stent groups.

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris:a substudy of the SORT OUT IV trial

Antonsen, Lisbeth
Thayssen, Per
Hansen, Henrik S
Maeng, Michael
Tilsted, Hans-Henrik
Bøtker, Hans Erik
Ravkilde, Jan
Madsen, Morten
Sørensen, Henrik T
Thuesen, Leif
Lassen, Jens Flensted
Jensen, Lisette O

January 2014

Aims: The aim of this substudy of the SORT OUT IV trial was to compare clinical outcomes among patie...

Baseline characteristics of patients who received SES, E-ZES and EES.

Chao-Lun Lai (588633)
Ching-Fen Wu (718069)
Raymond Nien-Chen Kuo (482097)
Yen-Yun Yang (718070)
Ming-Fong Chen (309336)
K. Arnold Chan (508228)
Mei-Shu Lai (215894)

April 2015

Abbreviations: ACEi: angotensin-converting-enzyme inhibitor; ACS: acute coronary syndrome, ARB: a...

Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting xience V stents in the randomized TWENTE trial: Comparison of 2-year clinical outcome

Sen, Hanim
Lam, Ming Kai
Tandjung, Kenneth
Löwik, Marije M.
Stoel, Martin G.
Man, Frits H.A.F. de
Louwerenburg, J. (Hans) W.
Houwelingen, Gert K. van
Linssen, Gerard C.M.
Doggen, Carine J.M.
Basalus, Mounir W. Z.
Birgelen, Clemens von

January 2015

Objective To assess the differences in clinical outcome between complex patients treated with Resolu...

Clinical end-points of patients receiving SES, E-ZES and EES.

Chao-Lun Lai (588633)
Ching-Fen Wu (718069)
Raymond Nien-Chen Kuo (482097)
Yen-Yun Yang (718070)
Ming-Fong Chen (309336)
K. Arnold Chan (508228)
Mei-Shu Lai (215894)

April 2015

Abbreviations: CI: confidence interval; EES: everolimus-eluting stent; E-ZES: Endeavor zotarolimu...

Relative risk of individual clinical end-point in two composite end-points among E-ZES and EES groups.

Chao-Lun Lai (588633)
Ching-Fen Wu (718069)
Raymond Nien-Chen Kuo (482097)
Yen-Yun Yang (718070)
Ming-Fong Chen (309336)
K. Arnold Chan (508228)
Mei-Shu Lai (215894)

April 2015

The SES group was used as the reference. Abbreviations: CABG: coronary artery bypass grafting; CI...

Flow chart of the study.

Chao-Lun Lai (588633)
Ching-Fen Wu (718069)
Raymond Nien-Chen Kuo (482097)
Yen-Yun Yang (718070)
Ming-Fong Chen (309336)
K. Arnold Chan (508228)
Mei-Shu Lai (215894)

April 2015

Abbreviations: CABG: coronary artery bypass grafting; DES: drug-eluting stent; EES: everolimus-el...

Kaplan-Meier Curves of Estimated Cumulative Incidence of Outcomes.

Chetan Shenoy (326704)
Judy Boura (359428)
Pamela Orshaw (359430)
Kishore J. Harjai (359433)

February 2013

The estimated cumulative incidences of all-cause death (A), MI (B), ST (C), TVR (D) and MACE (E) ...

2-Year Patient-Related Versus Stent-Related Outcomes The SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial

Jensen, Lisette Okkels
Thayssen, Per
Christiansen, Evald Høj
Tilsted, Hans Henrik
Maeng, Michael
Hansen, Knud Nørregaard
Kaltoft, Anne
Hansen, Henrik Steen
Bøtker, Hans Erik
Krusell, Lars Romer
Ravkilde, Jan
Madsen, Morten
Thuesen, Leif
Lassen, Jens Flensted

September 2012

ObjectivesThere are limited head-to-head randomized data on patient-related versus stent-related out...

Clinical Outcomes in Low Risk Coronary Artery Disease Patients Treated with Different Limus-Based Drug-Eluting Stents - A Nationwide Retrospective Cohort Study Using Insurance Claims Database

Lai, Chao-Lun
賴超倫

June 2017

The clinical outcomes of different limus-based drug-eluting stents (DES) in a real-world setting hav...

Kaplan-Meier curves for clinical outcomes in all the patients (A, B) and the propensity-matched patients (C, D).

Jong-Hwa Ahn (2836769)
Jeong Hoon Yang (795015)
Cheol Woong Yu (2836763)
Je Sang Kim (2836772)
Hyun Jong Lee (2836757)
Rak Kyeong Choi (2836760)
Tae Hoon Kim (128536)
Ho Joon Jang (2836754)
Young Jin Choi (1527340)
Young Moo Roh (2836766)
Won-Heum Shim (2836751)
Young Bin Song (843567)
Joo-Yong Hahn (843568)
Jin-Ho Choi (288185)
Sang Hoon Lee (211083)
Hyeon-Cheol Gwon (288186)
Seung-Hyuk Choi (288187)

June 2016

Kaplan-Meier curves for cardiac death and MACE in the patients treated with first-generation and ...

Clinical outcomes in low risk coronary artery disease patients treated with different limus-based drug-eluting stents--a nationwide retrospective cohort study using insurance claims database.

Chao-Lun Lai
Ching-Fen Wu
Raymond Nien-Chen Kuo
Yen-Yun Yang
Ming-Fong Chen
K Arnold Chan
Mei-Shu Lai

The clinical outcomes of different limus-based drug-eluting stents (DES) in a real-world setting hav...

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

Camenzind, Edoardo
Wijns, William
Mauri, Laura
Kurowski, Volkhard
Parikh, Keyur
Gao, Runlin
Bode, Christoph
Greenwood, John P
Boersma, Eric
Vranckx, Pascal
McFadden, Eugene
Serruys, Patrick W
O'Neil, William W
Jorissen, Brenda
Van Leeuwen, Frank
Steg, Ph Gabriel
Protect steering committee and investigators
Desmet, Walter

October 2012

We sought to compare the long-term safety of two devices with different antiproliferative properties...

Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes

Kalesan, Bindu
Stefanini, Giulio G
Räber, Lorenz
Schmutz, Mathieu
Baumgartner, Sandro
Hitz, Sarah
Baldinger, Samuel H
Pilgrim, Thomas
Moschovitis, Aris
Wenaweser, Peter
Büllesfeld, Lutz
Khattab, Ahmed A
Meier, Bernhard
Jüni, Peter
Windecker, Stephan

January 2012

The goal of this study was to compare the long-term clinical outcome between everolimus-eluting sten...

The Outcome of Sirolimus-Eluting Stent Treatment in a General Hospital

若林靖史
堀込実岐
山崎恭平

October 2008

Many studies have shown that a sirolimus-eluting stent (SES) decreases restenosis and target leision...

Kaplan-Meier curves of long-term mortality by EF groups in CES patients (A) and AF subgroup (B).

Jung-Ick Byun (554902)
Keun-Hwa Jung (168311)
Young-Dae Kim (446664)
Jeong-Min Kim (168316)
Jae-Kyu Roh (168360)

April 2014

Abbreviations: EF, Ejection fraction. CES: Cardioembolic stroke, AF: Atrial fibrillation.</p

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris:a substudy of the SORT OUT IV trial

Antonsen, Lisbeth
Thayssen, Per
Hansen, Henrik S
Maeng, Michael
Tilsted, Hans-Henrik
Bøtker, Hans Erik
Ravkilde, Jan
Madsen, Morten
Sørensen, Henrik T
Thuesen, Leif
Lassen, Jens Flensted
Jensen, Lisette O

January 2014

Aims: The aim of this substudy of the SORT OUT IV trial was to compare clinical outcomes among patie...

Baseline characteristics of patients who received SES, E-ZES and EES.

Chao-Lun Lai (588633)
Ching-Fen Wu (718069)
Raymond Nien-Chen Kuo (482097)
Yen-Yun Yang (718070)
Ming-Fong Chen (309336)
K. Arnold Chan (508228)
Mei-Shu Lai (215894)

April 2015

Abbreviations: ACEi: angotensin-converting-enzyme inhibitor; ACS: acute coronary syndrome, ARB: a...

Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting xience V stents in the randomized TWENTE trial: Comparison of 2-year clinical outcome

Sen, Hanim
Lam, Ming Kai
Tandjung, Kenneth
Löwik, Marije M.
Stoel, Martin G.
Man, Frits H.A.F. de
Louwerenburg, J. (Hans) W.
Houwelingen, Gert K. van
Linssen, Gerard C.M.
Doggen, Carine J.M.
Basalus, Mounir W. Z.
Birgelen, Clemens von

January 2015

Objective To assess the differences in clinical outcome between complex patients treated with Resolu...

Clinical end-points of patients receiving SES, E-ZES and EES.

Chao-Lun Lai (588633)
Ching-Fen Wu (718069)
Raymond Nien-Chen Kuo (482097)
Yen-Yun Yang (718070)
Ming-Fong Chen (309336)
K. Arnold Chan (508228)
Mei-Shu Lai (215894)

April 2015

Abbreviations: CI: confidence interval; EES: everolimus-eluting stent; E-ZES: Endeavor zotarolimu...

Relative risk of individual clinical end-point in two composite end-points among E-ZES and EES groups.

Chao-Lun Lai (588633)
Ching-Fen Wu (718069)
Raymond Nien-Chen Kuo (482097)
Yen-Yun Yang (718070)
Ming-Fong Chen (309336)
K. Arnold Chan (508228)
Mei-Shu Lai (215894)

April 2015

The SES group was used as the reference. Abbreviations: CABG: coronary artery bypass grafting; CI...

Flow chart of the study.

Chao-Lun Lai (588633)
Ching-Fen Wu (718069)
Raymond Nien-Chen Kuo (482097)
Yen-Yun Yang (718070)
Ming-Fong Chen (309336)
K. Arnold Chan (508228)
Mei-Shu Lai (215894)

April 2015

Abbreviations: CABG: coronary artery bypass grafting; DES: drug-eluting stent; EES: everolimus-el...

Kaplan-Meier Curves of Estimated Cumulative Incidence of Outcomes.

Chetan Shenoy (326704)
Judy Boura (359428)
Pamela Orshaw (359430)
Kishore J. Harjai (359433)

February 2013

The estimated cumulative incidences of all-cause death (A), MI (B), ST (C), TVR (D) and MACE (E) ...

2-Year Patient-Related Versus Stent-Related Outcomes The SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial

Jensen, Lisette Okkels
Thayssen, Per
Christiansen, Evald Høj
Tilsted, Hans Henrik
Maeng, Michael
Hansen, Knud Nørregaard
Kaltoft, Anne
Hansen, Henrik Steen
Bøtker, Hans Erik
Krusell, Lars Romer
Ravkilde, Jan
Madsen, Morten
Thuesen, Leif
Lassen, Jens Flensted

September 2012

ObjectivesThere are limited head-to-head randomized data on patient-related versus stent-related out...

Clinical Outcomes in Low Risk Coronary Artery Disease Patients Treated with Different Limus-Based Drug-Eluting Stents - A Nationwide Retrospective Cohort Study Using Insurance Claims Database

Lai, Chao-Lun
賴超倫

June 2017

The clinical outcomes of different limus-based drug-eluting stents (DES) in a real-world setting hav...

Kaplan-Meier curves for clinical outcomes in all the patients (A, B) and the propensity-matched patients (C, D).

Jong-Hwa Ahn (2836769)
Jeong Hoon Yang (795015)
Cheol Woong Yu (2836763)
Je Sang Kim (2836772)
Hyun Jong Lee (2836757)
Rak Kyeong Choi (2836760)
Tae Hoon Kim (128536)
Ho Joon Jang (2836754)
Young Jin Choi (1527340)
Young Moo Roh (2836766)
Won-Heum Shim (2836751)
Young Bin Song (843567)
Joo-Yong Hahn (843568)
Jin-Ho Choi (288185)
Sang Hoon Lee (211083)
Hyeon-Cheol Gwon (288186)
Seung-Hyuk Choi (288187)

June 2016

Kaplan-Meier curves for cardiac death and MACE in the patients treated with first-generation and ...

Clinical outcomes in low risk coronary artery disease patients treated with different limus-based drug-eluting stents--a nationwide retrospective cohort study using insurance claims database.

Chao-Lun Lai
Ching-Fen Wu
Raymond Nien-Chen Kuo
Yen-Yun Yang
Ming-Fong Chen
K Arnold Chan
Mei-Shu Lai

The clinical outcomes of different limus-based drug-eluting stents (DES) in a real-world setting hav...

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

Camenzind, Edoardo
Wijns, William
Mauri, Laura
Kurowski, Volkhard
Parikh, Keyur
Gao, Runlin
Bode, Christoph
Greenwood, John P
Boersma, Eric
Vranckx, Pascal
McFadden, Eugene
Serruys, Patrick W
O'Neil, William W
Jorissen, Brenda
Van Leeuwen, Frank
Steg, Ph Gabriel
Protect steering committee and investigators
Desmet, Walter

October 2012

We sought to compare the long-term safety of two devices with different antiproliferative properties...

Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes

Kalesan, Bindu
Stefanini, Giulio G
Räber, Lorenz
Schmutz, Mathieu
Baumgartner, Sandro
Hitz, Sarah
Baldinger, Samuel H
Pilgrim, Thomas
Moschovitis, Aris
Wenaweser, Peter
Büllesfeld, Lutz
Khattab, Ahmed A
Meier, Bernhard
Jüni, Peter
Windecker, Stephan

January 2012

The goal of this study was to compare the long-term clinical outcome between everolimus-eluting sten...

The Outcome of Sirolimus-Eluting Stent Treatment in a General Hospital

若林靖史
堀込実岐
山崎恭平

October 2008

Many studies have shown that a sirolimus-eluting stent (SES) decreases restenosis and target leision...

Kaplan-Meier curves of long-term mortality by EF groups in CES patients (A) and AF subgroup (B).

Jung-Ick Byun (554902)
Keun-Hwa Jung (168311)
Young-Dae Kim (446664)
Jeong-Min Kim (168316)
Jae-Kyu Roh (168360)

April 2014

Abbreviations: EF, Ejection fraction. CES: Cardioembolic stroke, AF: Atrial fibrillation.</p

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris:a substudy of the SORT OUT IV trial

Antonsen, Lisbeth
Thayssen, Per
Hansen, Henrik S
Maeng, Michael
Tilsted, Hans-Henrik
Bøtker, Hans Erik
Ravkilde, Jan
Madsen, Morten
Sørensen, Henrik T
Thuesen, Leif
Lassen, Jens Flensted
Jensen, Lisette O

January 2014

Aims: The aim of this substudy of the SORT OUT IV trial was to compare clinical outcomes among patie...

Baseline characteristics of patients who received SES, E-ZES and EES.

Chao-Lun Lai (588633)
Ching-Fen Wu (718069)
Raymond Nien-Chen Kuo (482097)
Yen-Yun Yang (718070)
Ming-Fong Chen (309336)
K. Arnold Chan (508228)
Mei-Shu Lai (215894)

April 2015

Abbreviations: ACEi: angotensin-converting-enzyme inhibitor; ACS: acute coronary syndrome, ARB: a...

Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting xience V stents in the randomized TWENTE trial: Comparison of 2-year clinical outcome

Sen, Hanim
Lam, Ming Kai
Tandjung, Kenneth
Löwik, Marije M.
Stoel, Martin G.
Man, Frits H.A.F. de
Louwerenburg, J. (Hans) W.
Houwelingen, Gert K. van
Linssen, Gerard C.M.
Doggen, Carine J.M.
Basalus, Mounir W. Z.
Birgelen, Clemens von

January 2015

Objective To assess the differences in clinical outcome between complex patients treated with Resolu...

Kaplan-Meier cumulative incidences of different clinical end-points in three stent groups.

Abstract

Extracted data

Kaplan-Meier cumulative incidences of different clinical end-points in three stent groups.

Abstract

Extracted data

Topics

Related items

Topics

Related items